Package Leaflet: Information for the User
oxcarbazepine cinfa300 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is oxcarbazepine cinfa
The active substance of oxcarbazepine cinfa is oxcarbazepine.
Oxcarbazepine belongs to a group of medicines called anticonvulsants or antiepileptics.
What is oxcarbazepine cinfa used for
Medicines like oxcarbazepine are the standard treatment for epilepsy.
Epilepsy is a brain disorder that causes people to have recurring seizures and convulsions. Seizures occur due to a temporary failure in the brain's electrical activity. Normally, brain cells coordinate body movements by sending signals through muscle nerves in an orderly organized manner. In epilepsy, brain cells send too many signals in a disordered manner. The result can be uncoordinated muscle activity known as an epileptic seizure.
Oxcarbazepine is used to treat partial epileptic seizures with or without secondary generalization with tonic-clonic seizures. Partial seizures involve a limited area of the brain but can spread to the entire brain and produce generalized tonic-clonic seizures. There are 2 types of partial seizures: simple and complex. In simple partial seizures, the patient remains conscious, while in complex seizures, the state of consciousness is altered.
Oxcarbazepine works by keeping the brain's overexcited nerve cells under control, thereby suppressing or reducing the frequency of these seizures.
Oxcarbazepine can be used alone or in combination with other antiepileptic medicines. Normally, your doctor will try to find the medicine that works best for you or your child. However, in severe epilepsy, you may need a combination of two or more medicines to control seizures. Oxcarbazepine is indicated for use in adults and children aged 6 years and above.
If you have any doubts about how oxcarbazepine works or why you have been prescribed this medicine, ask your doctor.
Follow carefully all the instructions given by your doctor, even if they differ from the general information provided in this leaflet.
Monitoring during treatment with oxcarbazepine
Before and during treatment with oxcarbazepine, your doctor may perform a blood test to establish your dose. Your doctor will tell you when to have the tests.
Do not take oxcarbazepine cinfa
If you are allergic, inform your doctor before taking oxcarbazepine. If you think you are allergic, ask your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take oxcarbazepine cinfa
The risk of serious skin reactions in Han Chinese or Thai patients associated with carbamazepine or chemically related compounds can be predicted by blood tests in these patients. Your doctor will advise you if a blood test is necessary before taking oxcarbazepine.
If you notice any of the following symptoms after taking oxcarbazepine, inform your doctor immediately or go to the Emergency Department of the nearest hospital:
Children and adolescents
For treatment in children, your doctor may recommend monitoring thyroid function before and during treatment.
Other medicines and oxcarbazepine cinfa
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Especially in the case of:
Taking oxcarbazepine cinfa with food, drinks, and alcohol
Oxcarbazepine can be taken with or without food. During treatment with oxcarbazepine, avoid taking alcoholic beverages, as it may increase the sedative effects of this medicine; if in doubt, consult your doctor.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
It is essential to control epileptic seizures during pregnancy. However, there may be a risk to your baby if you take antiepileptic medicines during pregnancy.
Congenital malformations
Studies have not shown an increased risk of congenital malformations associated with oxcarbazepine administered during pregnancy; however, it cannot be entirely ruled out that there is a risk of congenital malformations in the fetus.
Neurodevelopmental disorders
Some studies have shown that exposure to oxcarbazepine in the womb affects the development of brain function (neurodevelopment) in children negatively, while in other studies, this effect has not been observed. The possibility that there is an effect on neurodevelopment cannot be ruled out.
Birth weight
If you use oxcarbazepine during pregnancy, your child may have a low birth weight and weigh less than expected at birth [small size for gestational age (SGA)]. Among women with epilepsy, in one study, around 15 out of 100 children born to mothers who had taken oxcarbazepine during pregnancy were smaller and weighed less than expected at birth, compared to around 11 out of 100 children born to women who had not taken anticonvulsant medication during pregnancy.
Your doctor will inform you of the benefits and possible risks of treatment and help you decide whether you should take oxcarbazepine.
Do not stop your treatment with oxcarbazepine without consulting your doctor.
Breastfeeding
If you are taking this medicine, ask your doctor before starting breastfeeding. The active substance of oxcarbazepine cinfa passes into breast milk. Although the available data suggest that the amount of oxcarbazepine cinfa that passes to the breastfed child is low, a risk of side effects in the baby cannot be ruled out.
Your doctor will inform you of the benefits and potential risks of breastfeeding while using oxcarbazepine cinfa. If you are breastfeeding during treatment with oxcarbazepine cinfa and think your baby is experiencing any side effects such as excessive sleepiness or poor weight gain, inform your doctor immediately.
Driving and using machines
Oxcarbazepine may cause symptoms such as drowsiness, dizziness, or vision changes, and may reduce your reaction ability. These effects, as well as the disease itself, may impair your ability to drive vehicles or operate machines. Therefore, do not drive, operate machines, or engage in other activities that require special attention until your doctor assesses your response to this medicine.
Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
How much to take
Use in adults
Use in children
Oxcarbazepine can be used in children aged 6 years and above.
The recommended dose for children is calculated based on weight.
How to take oxcarbazepine cinfa
When and for how long to take oxcarbazepine cinfa
Take oxcarbazepine twice a day, every day, approximately at the same time of day, unless your doctor tells you otherwise. This will have the best effect for controlling epilepsy. It will also help you remember when to take the tablet or tablets.
Your doctor will inform you how long your treatment or your child's treatment will last. The duration of treatment will depend on the type of seizures you or your child suffer from. You may need to continue treatment for several years to control epileptic seizures. Do not change the dose or stop treatment without talking to your doctor first.
If you take more oxcarbazepine cinfa than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested. The symptoms of oxcarbazepine overdose may include:
If you forget to take oxcarbazepine cinfa
If you have missed a single dose, take it as soon as you can, except if it is almost time for the next dose; in this case, wait and return to the recommended administration schedule.
If you are unsure or have missed several doses, inform your doctor. Do not take a double dose to make up for the missed doses.
If you stop taking oxcarbazepine cinfa
Do not stop taking your medicine without consulting your doctor first.
To prevent a sudden worsening of seizures, do not stop treatment abruptly. If your treatment is stopped, it should be done gradually as indicated by your doctor.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Tell your doctor immediately or go to the emergency department of the nearest hospital if you experience any of the following adverse effects:
The following are symptoms of potentially serious adverse effects that may require urgent medical treatment.
Your doctor will decide whether to stop treatment with oxcarbazepine immediately and how to continue your treatment in the future.
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very Rare(may affect up to 1 in 10,000 people):
Tell your doctor as soon as possible if you experience any of the following adverse effects.They may require medical attention.
Common(may affect up to 1 in 10 people):
Very Rare(may affect up to 1 in 10,000 people):
Other Adverse Effects that May Occur
These are mild to moderate adverse effects of oxcarbazepine. Most of these effects are transient and usually decrease over time.
Very Common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and blister pack after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Oxcarbazepine Cinfa
Tablet core;microcrystalline cellulose, povidone K30, crospovidone, anhydrous colloidal silica, and magnesium stearate.
Tablet coating;hypromellose, titanium dioxide (E-171), and macrogol.
It also contains yellow iron oxide (E-172).
Appearance of the Product and Package Contents
Coated tablets, cylindrical, biconvex, scored, yellow in color, and coded “O3”.
The film-coated tablets are presented in blister packs. Each package contains 50, 100, or 500 (clinical package) tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) - Spain
Date of the Last Revision of this Leaflet:July 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/77722/P_77722.html
QR code to: https://cima.aemps.es/cima/dochtml/p/77722/P_77722.html
The average price of OXCARBAZEPINE CINFA 300 mg FILM-COATED TABLETS in October, 2025 is around 22.06 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.